Rebastinib
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-13024-10 mg |
| CAS # | 1020172-07-9 |
| Pricing | 10 mg, USD $120.0 |
| Synonyms | DCC-2036 |
| MWt | 553.59 |
| Formula | C₃₀H₂₈FN₇O₃ |
| Biological Activity | Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit. |
| Purity | ≥98.0% |